Navigation Links
GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
Date:11/10/2011

ATLANTA, Nov. 10, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm (the "Company") developing vaccines that prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced its financial results for the nine months ended September 30, 2011.

GeoVax reported a net loss of $375,852 ($0.02 per share) for the three months ended September 30, 2011, compared to $644,666 ($0.04 per share) for the same period in 2010. For the nine months ended September 30, 2011, the Company's net loss was $1,193,478 ($0.08 per share) as compared to $2,268,544 ($0.14 per share) for the same period in 2010.  Net losses were partially offset by revenues related to the Company's grant from the NIH in support of its HIV/AIDS vaccine development activities; such revenues were $1,297,006 and $3,943,041 for the three month and nine month periods of 2011, respectively, as compared to $1,163,288 and $4,239,017 for the three month and nine month periods of 2010, respectively.  As of September 30, 2011, the Company reported cash balances totaling $566,657, as compared to $1,079,087 at December 31, 2010.

GeoVax President and CEO Robert T. McNally, PhD, commented, "GeoVax continued to make solid progress during the third quarter of 2011. Our 299 participant Phase 2a clinical trial for the preventative version of our HIV/AIDS vaccine is fully enrolled and we expect patient inoculations to be completed during early 2012 with study analysis and completion during 2012. This trial is being conducted by the HIV Trials Network (HVTN), funded by the NIH. A preliminary unblinding of data from part 1 of this study showed elicitation of unexpectedly high response rates of neutralizing antibody for tier 2 isolates of HIV-1. The elicitation of neutralizing antibody for tier 2 viruses is an important result because tier 2 viruses represent viruses that undergo the most frequent transmission from an infected person to an uninf
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
2. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
3. GeoVax Presents Data at AIDS Vaccine 2008 Conference
4. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
5. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
6. GeoVax to Present at the BIO CEO & Investor Conference 2009
7. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
8. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
10. GeoVax Labs, Inc. Announces First Quarter Financial Results
11. GeoVax to Exhibit at the 2009 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... have developed what they believe is the thinnest-possible ... in sheets only three atoms thick. , The ... of these single-layer semiconductor materials can be connected ... heterojunction. This result could be the basis for ... or LEDs, and solar technologies. , "Heterojunctions are ...
(Date:8/26/2014)... An analysis by Replikins, Ltd. of Pubmed data of ... virus strains has revealed extensive conservation and sharing of ... sharing of specific Replikin gene structures has permitted the ... did for the H5N1 influenza vaccine and the Taura ... to be effective (1,2). This ...
(Date:8/26/2014)... argument has just been added to the growing ... as the next big thing in the high-tech ... materials. An international collaboration of researchers led by ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) has ... transfer in photo-excited MX2 materials. The recorded charge ...
(Date:8/26/2014)...  ViveBio, LLC a leading provider of products ... announced today that it has signed a distribution ... Knoxville, Tennessee to distribute ... United States . ViveST is the first ... biological specimen transport systems.  The technology enables easy, ...
Breaking Biology Technology:Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2Competition for graphene 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2
... economic growth. , ,Six months ago I wrote ... Article Knocks the Rust Off State Manufacturing Outlook, that recounted ... an interview from a December edition of Barrons Magazine. In ... U.S. recovery in a quarter of a century and that ...
... Medical Systems has announced that its Vericis system ... terabytes of storage for digital cardiovascular images and other ... years worth of study results, which clinicians will be ... over the Web from outreach clinics. In such a ...
... so- called social networks, services such as LinkedIn, Spoke, and ... "I'm LinkedIn - Now What," and they have questioned the ... wasn't being critical, really; I just didn't see a clear ... in recent weeks, I've experienced one "a-ha" moment after another, ...
Cached Biology Technology:Hey Willie, Wisconsin Manufacturing Doesnt Need an Aid Concert! 2Hey Willie, Wisconsin Manufacturing Doesnt Need an Aid Concert! 3Social networks and my big a-ha 2Social networks and my big a-ha 3Social networks and my big a-ha 4
(Date:8/27/2014)... Now that health advocates, campaigns against trans-fats have ... additive, they,re taking aim at sugar for its ... and policymakers are still wrangling over the best ... according to an article in Chemical & ... of the American Chemical Society. , In the ...
(Date:8/27/2014)... the main factors thought to be associated with ... are the age of the patient, mechanism of ... time, repair method, operation technique, and repair materials. ... repair of peripheral nerve injuries, there is no ... prognosis, and the dose-effect relationship of the predictors ...
(Date:8/27/2014)... Complex of fires had consumed 24,939 acres of land ... as of eight hours ago. , Lightning strikes ... of the Klamath National Forest when a thunderstorm passed ... three of those fires are now 100 percent contained. ... their size at containment: Delta, 150 acres; Sutcliffe, 27 ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2
... Inherited diseases such as cystic fibrosis can be caused ... cells make proteins. David Bedwell, Ph.D., a professor in ... Microbiology, says scientists are now closer to producing drugs ... of genetic disease. Bedwell is a renowned researcher ...
... , ANAHEIM, CA: Can eating less be as simple as ... According to a team of researchers from Cornell University, it can. ... Calif., researchers led by Brian Wansink, director of the Cornell Food ... study of 78 adults. "We looked at whether serving ...
... of monitor lizard, a close relative of the Komodo dragon, ... by a professor at UC Santa Barbara and a researcher ... of Ecology, Evolution and Marine Biology at UCSB, and Valter ... Finland, are the first to describe the distinctive lizard, which ...
Cached Biology News:Drug may treat cystic fibrosis, other diseases caused by 'nonsense mutations,' UAB researcher says 2New monitor lizard discovered in Indonesia 2